Global Key Solutions Corp. (GKS), a leader in regulatory intelligence and quality compliance technology, has launched KeyPedia™, an AI-driven platform designed specifically for the pharmaceutical quality sector. This announcement was made on February 10, 2026, in New York City, coinciding with a rebranding effort to better reflect the company’s core values of quality, innovation, urgency, and harmony.
KeyPedia aims to transform intricate global regulatory data into actionable compliance insights for pharmaceutical, biotech, and medical device manufacturers. It provides real-time tracking of compliance requirements, FDA inspection data, and Chemistry, Manufacturing, and Controls (CMC) regulations, going beyond traditional sources like FDA warning letters to include comprehensive information from over 20 health authorities worldwide.
The platform leverages a proprietary database containing over 1.5 million regulatory data points, facilitating proactive risk management. “Quality and regulatory teams are under increasing pressure to stay ahead of global compliance requirements that change daily,” stated GKS CEO George Kwiecinski. He emphasized that KeyPedia equips users with a unified AI-powered platform to monitor regulatory changes across more than 80 agencies globally.
KeyPedia is composed of specialized modules aimed at enhancing pharmaceutical quality operations across various workflows. These include KeyPedia Legal, which assists in drafting responses to FDA Form 483; KeyPedia Audit, designed for generating unbiased observations during internal audits; KeyPedia Investigator, which provides comprehensive regulatory histories for firms and industries; and KeyPedia Internal, which focuses on compliance data management and organization.
Among its significant features, KeyPedia offers proactive risk management capabilities. The AI continuously monitors regulatory changes and generates risk profiles for firms, manufacturing sites, and inspectors, allowing compliance teams to address potential non-compliance issues before they escalate into enforcement actions. This functionality reflects a growing trend in the life sciences sector where companies face mounting regulatory scrutiny.
Real-time monitoring across agencies such as the FDA, EMA, MHRA, and Health Canada is central to KeyPedia’s offerings. The platform also promises to enhance operational efficiency by automating regulatory data gathering and analysis, which can significantly reduce the manual hours needed for audit preparation and regulatory response timelines.
KeyPedia Lite is currently available at no cost through the GKS website, providing a gateway for professionals to experience the platform’s capabilities. For those seeking to unlock its full potential, GKS offers various plans and programs tailored to meet the needs of the life sciences industry.
Global Key Solutions Corp. is committed to supporting pharmaceutical, biotech, and medical device manufacturers in navigating complex global regulatory environments through data-driven insights and automation. As compliance standards continue to evolve, platforms like KeyPedia are poised to play a crucial role in helping companies maintain their competitive edge.
See also
OpenAI’s Rogue AI Safeguards: Decoding the 2025 Safety Revolution
US AI Developments in 2025 Set Stage for 2026 Compliance Challenges and Strategies
Trump Drafts Executive Order to Block State AI Regulations, Centralizing Authority Under Federal Control
California Court Rules AI Misuse Heightens Lawyer’s Responsibilities in Noland Case
Policymakers Urged to Establish Comprehensive Regulations for AI in Mental Health
